Tag: Cobas

All

Lipoprotein(a), or Lp(a), is a genetically determined and under-recognized cardiovascular disease risk factor.

The U.S. FDA granted Emergency Use Authorization (EUA) for Roche’s cobas MPXV for use on the cobas 6800/8800 Systems.

The test is intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B.

The new test from Roche expands the menu for healthcare-associated infections testing on the widely adopted Cobas 4800 system.